We are live on ! Find out more
JAFL

Jay A. Fishman Ltd Portfolio holdings

AUM $1.12B
1-Year Est. Return 32.75%
This Fund
S&P 500
This Quarter Est. Return
+9.67%
1 Year Est. Return
+32.75%
3 Year Est. Return
+106.85%
5 Year Est. Return
+144.56%
10 Year Est. Return
+606.28%
AUM
$530M
AUM Growth
+$40M
Cap. Flow
+$1.43M
Cap. Flow %
0.27%
Top 10 Hldgs %
57%
Holding
96
New
3
Increased
30
Reduced
33
Closed
6

Top Buys

Rank Stock Value
1
INTC icon
Intel
INTC
+$6.9M
2
LEN icon
Lennar Class A
LEN
+$6.32M
3
HD icon
Home Depot
HD
+$2.34M
4
GM icon
General Motors
GM
+$2.29M
5
AMZN icon
Amazon
AMZN
+$1.69M

Top Sells

Rank Stock Value
1
AGN
Allergan plc
AGN
+$10.1M
2
CELG
Celgene Corp
CELG
+$3.6M
3
SBUX icon
Starbucks
SBUX
+$2.75M
4
MDT icon
Medtronic
MDT
+$826K
5
CVS icon
CVS Health
CVS
+$767K

Sector Composition

Rank Sector Weight
1 Industrials 19.39%
2 Technology 17.57%
3 Healthcare 15.13%
4 Financials 14.11%
5 Consumer Discretionary 12.47%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
VO icon
51
Vanguard Mid-Cap ETF
VO
$107B
$1.11M 0.21%
28,644
+2,256
+9% +$85.2K
LKQ icon
52
LKQ Corp
LKQ
$6.69B
$1.1M 0.21%
27,000
– –
CVX icon
53
Chevron
CVX
$378B
$1.08M 0.2%
8,637
– –
EEM icon
54
iShares MSCI Emerging Markets ETF
EEM
$28.6B
$1.03M 0.19%
21,800
+3,000
+16% +$139K
ABBV icon
55
AbbVie
ABBV
$454B
$876K 0.17%
9,056
– –
CMCSA icon
56
Comcast
CMCSA
$80.9B
$861K 0.16%
21,500
-200
-0.9% -$7.52K
PM icon
57
Philip Morris
PM
$305B
$853K 0.16%
8,077
– –
CVS icon
58
CVS Health
CVS
$137B
$749K 0.14%
10,332
-10,552
-51% -$767K
BRK.A icon
59
Berkshire Hathaway Class A
BRK.A
$1.07T
$595K 0.11%
2
– –
ITW icon
60
Illinois Tool Works
ITW
$81.9B
$584K 0.11%
3,500
-50
-1% -$7.97K
PEP icon
61
PepsiCo
PEP
$191B
$584K 0.11%
4,869
+536
+12% +$61.2K
F icon
62
Ford
F
$58.5B
$535K 0.1%
+42,861
New +$528K
VWO icon
63
Vanguard FTSE Emerging Markets ETF
VWO
$120B
$534K 0.1%
11,638
+1,305
+13% +$58.3K
MMM icon
64
3M
MMM
$91.9B
$497K 0.09%
2,527
-233
-8% -$44.8K
MSFT icon
65
Microsoft
MSFT
$2.89T
$496K 0.09%
5,799
+808
+16% +$66.3K
C icon
66
Citigroup
C
$223B
$489K 0.09%
6,568
+935
+17% +$69.1K
RL icon
67
Ralph Lauren
RL
$22.6B
$487K 0.09%
4,700
– –
XOM icon
68
ExxonMobil
XOM
$642B
$444K 0.08%
5,309
-75
-1% -$6.2K
ABT icon
69
Abbott
ABT
$182B
$437K 0.08%
7,664
– –
IWM icon
70
iShares Russell 2000 ETF
IWM
$80.3B
$396K 0.07%
2,600
– –
MCO icon
71
Moody's
MCO
$84.2B
$395K 0.07%
2,675
-250
-9% -$36.6K
ZTS icon
72
Zoetis
ZTS
$32.2B
$356K 0.07%
4,938
– –
NWL icon
73
Newell Brands
NWL
$2.2B
$352K 0.07%
11,400
-8,200
-42% -$283K
MDLZ icon
74
Mondelez International
MDLZ
$77.9B
$348K 0.07%
8,140
+375
+5% +$15.7K
TEX icon
75
Terex
TEX
$7.89B
$347K 0.07%
7,200
– –
1 2
3
4

Similar funds

SL
Salomon & Ludwin Richmond, Virginia $1.12B AUM 14.38% 1-Year Est. Return
PTC
Private Trust Company Cleveland, Ohio $1.12B AUM 21.35% 1-Year Est. Return
CT
Caldwell Trust Venice, Florida $1.12B AUM 21.31% 1-Year Est. Return
C
Chescapmanager Baltimore, Maryland $1.12B AUM 67.49% 1-Year Est. Return
CNC
Canandaigua National Corp Canandaigua, New York $1.12B AUM
MTCM
Mint Tower Capital Management Amsterdam, Netherlands $1.12B AUM 19.06% 1-Year Est. Return
EC
Estate Counselors Thiensville, Wisconsin $1.12B AUM 20.13% 1-Year Est. Return
AIM
Advyzon Investment Management Lisle, Illinois $1.12B AUM 22.08% 1-Year Est. Return

Jay A. Fishman Ltd's Q4 2017 Portfolio in Review

As of Q4 2017, Jay A. Fishman Ltd held 96 positions worth $530M, up 8.1% from $490M the previous quarter. Its ten largest holdings account for 57% of the portfolio.

Jay A. Fishman Ltd's Q4 2017 filing shows 3 new, 30 increased, 33 reduced and 6 closed positions. Its largest new stake was Ford: 42,861 shares worth $535K. The largest sale was Allergan plc, an estimated $10.1M.

By sector, the portfolio is most concentrated in Industrials at 19% of assets, up from 18% a quarter earlier, followed by Technology and Healthcare.

  • Jay A. Fishman Ltd's largest Q4 2017 buy was Ford: 42,861 shares worth $535K.
  • Jay A. Fishman Ltd added most to Intel in Q4 2017, an estimated $6.9M increase.
  • Jay A. Fishman Ltd's biggest Q4 2017 reduction was Allergan plc, cutting an estimated $10.1M.
  • Jay A. Fishman Ltd fully exited Celgene Corp in Q4 2017, selling an estimated $3.6M.
  • Jay A. Fishman Ltd's ten largest holdings make up 57% of its $530M portfolio in Q4 2017.
  • Jay A. Fishman Ltd opened 3 new positions and closed 6 in Q4 2017.
  • Jay A. Fishman Ltd's portfolio value rose 8.1% quarter-over-quarter to $530M.

Based on Jay A. Fishman Ltd's 13F filing for Q4 2017, filed 5 Feb 2018.